Clinical evidence
2005-06-01
Obesity.
David Arterburn, David DeLaet, David Flum
Index: Clin. Evid. (13) , 707-25, (2005)
Full Text: HTML
Abstract
Related Articles:
Development and validation of an LC-MS/MS method for the simultaneous analysis of 28 specific narcotic adulterants used in dietary supplements.
2015-01-01
[Food Addit. Contam. Part A. Chem. Anal. Control. Expo. Risk Assess. 32 , 1029-39, (2015)]
Plasma membrane monoamine transporters: structure, regulation and function.
2003-01-01
[Nat. Rev. Neurosci. 4 , 13-25, (2003)]
Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA(A) receptor alpha1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilateral 6-hydroxydopamine lesion.
2008-06-26
[Neuroscience 154(3) , 1088-99, (2008)]
Study on detection of drugs in slimming health foods using GC-MS/MS.
2011-01-01
[Shokuhin Eiseigaku Zasshi 52(6) , 363-9, (2011)]
Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
2014-10-01
[Neurobiol. Aging 35(10) , 2347-56, (2014)]